SCHEMBL28280223

SCHEMBL28280223

CN1Cc2cccc(Cl)c2CC1C=O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ADRA2A P08913 2/20 0.41
▸ ADRA2B P18089 2/20 0.41
▸ ADRA2C P18825 2/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ ADRA1D P25100 1/20 0.41
▸ ADRA1A P35348 1/20 0.41
▸ ADRA1B P35368 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ NAMPT P43490 2/20 0.36
▸ ACHE P22303 1/20 0.36
▸ DRD2 P14416 3/20 0.35
▸ CTSD P07339 1/20 0.35
▸ DRD3 P35462 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ ACACB O00763 1/20 0.33
▸ AADAT Q8N5Z0 1/20 0.33
▸ NOTUM Q6P988 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13681899 0.77 OPRM1 (0.39) CYP2D6ACHECYP1A2NOTUM
SCHEMBL2089551 0.77 OPRM1 (0.39) CYP2D6ACHECYP1A2NOTUM
SCHEMBL32677131 0.76 ADRA2A (0.41) ADRA2AADRA2BADRA2CCYP2D6ADRA1D
SCHEMBL32677026 0.76 ADRA2A (0.41) ADRA2AADRA2BADRA2CCYP2D6ADRA1D
SCHEMBL32676785 0.76 ADRA2A (0.41) ADRA2AADRA2BADRA2CCYP2D6ADRA1D
SCHEMBL32677197 0.74 ADRA2A (0.40) ADRA2AADRA2BADRA2CCYP2D6ADRA1D
SCHEMBL32677206 0.74 ADRA2A (0.40) ADRA2AADRA2BADRA2CCYP2D6ADRA1D
SCHEMBL32676801 0.74 ADRA2A (0.40) ADRA2AADRA2BADRA2CCYP2D6ADRA1D
SCHEMBL23856659 0.70 HTR1A (0.38) ADRA2AADRA2BADRA2CCYP2D6ADRA1D
SCHEMBL30046702 0.70 HTR1A (0.38) ADRA2AADRA2BADRA2CCYP2D6ADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109476663-A PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER 基因泰克公司 2019-03-15 — — CN disclosed
Send feedback